PTL: Maternal Serum Level of ACTH as a Predictive Marker of Preterm Labor in Patients With Threatened Preterm Labor
Study Details
Study Description
Brief Summary
The aim of this study is use of ACTH as a predictive marker in patients of threatened preterm labor .
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
This is a cross sectional study that will include 261 pregnant women aged between 17 and 35 years with singleton pregnancies between 28 and 36 completed weeks of gestation that had been diagnosed with threatened preterm labor and consented to participate in this study. This study will be conducted at Ain Shams University Maternity Hospital after approval of the research and ethics committee.
the investigators include all patients which have these following criteria (Singleton pregnancy, Age between 17 - 35 years, Gestational age between 28 and 36 weeks and Diagnosis of threatened preterm labor is based on the American College of Obstetricians and Gynaecologists Guidelines (ACOG, 2003): Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation > 1 and < 4 cm, and/or Cervical effacement ≥ 80%.
the investigators exclude any patient which has any of the following criteria (Preterm rupture of membranes, Any uterine anomalies or cervical incompetence, Chronic illness such as chronic hypertension or kidney disease, Diabetes mellitus, Abruptio placenta, Preeclampsia and HELLP syndrome, Fetal anomalies, IUGR, Smoking or Clinical signs of intrauterine infection).
blood sample was collected from each patient for measurement of ACTH level. According to local protocol in Ain Shams University Maternity Hospital all women will receive a fixed regimen of tocolysis in the form of nifedipine (Epilat) 10 mg orally every 15 minutes for the first hour or until cessation of uterine contractions. Then, 60 - 160 mg/day (1-2 tablets 3 times daily) of slowly releasing nifedipine (epilat retard 20 mg tablet) may be given depending on uterine activity. The patients will also receive 6 mg dexamethasone every 12 hours for 4 doses. All women will be followed up till delivery.
After delivery, the investigators divide the patients into 2 groups (full term delivery & preterm delivery) and we compare between these 2 groups by level of hormone.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
preterm group pregnant healthy women aged from 17 to 35 who suffered from symptoms of threatened preterm labor in the form of Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation > 1 and < 4 cm, and/or Cervical effacement ≥ 80%. collection of blood sample and tocolysis administration will be done this group will deliver preterm (before 37 weeks of gestation) |
Other: collection of blood sample and tocolysis adminstration
investigators will abtain a blood sample from all patient to measure the serum level of ACTH.
all patients with threatened preterm labor will receive a fixed regimen of tocolysis in the form of nifedipine (Epilate) 10 mg orally every 15 minutes for the first hour or until cessation of uterine contractions. Then, 60 - 160 mg/day (1-2 tablets 3 times daily) of slowly releasing nifedipine (epilat retard 20 mg tablet) may be given depending on uterine activity. The patients will also receive 6 mg dexamethasone every 12 hours for 4 doses. All women will be followed up till delivery.
After delivery, investigators devide the pateints into 2 groups (full term delivery & preterm delivery) and investigators compare between these 2 groups by level of hormone.
|
full term group pregnant healthy women aged from 17 to 35 who suffered from symptoms of threatened preterm labor in the form of Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation > 1 and < 4 cm, and/or Cervical effacement ≥ 80%. collection of blood sample and tocolysis administration will be done this group will deliver full term (after 37 weeks of gestation) |
Other: collection of blood sample and tocolysis adminstration
investigators will abtain a blood sample from all patient to measure the serum level of ACTH.
all patients with threatened preterm labor will receive a fixed regimen of tocolysis in the form of nifedipine (Epilate) 10 mg orally every 15 minutes for the first hour or until cessation of uterine contractions. Then, 60 - 160 mg/day (1-2 tablets 3 times daily) of slowly releasing nifedipine (epilat retard 20 mg tablet) may be given depending on uterine activity. The patients will also receive 6 mg dexamethasone every 12 hours for 4 doses. All women will be followed up till delivery.
After delivery, investigators devide the pateints into 2 groups (full term delivery & preterm delivery) and investigators compare between these 2 groups by level of hormone.
|
Outcome Measures
Primary Outcome Measures
- Evaluate if ACTH Can be Used as a Predictive Marker for Preterm Labor [9 weeks]
measurement of maternal serum ACTH in women daignosed as threatened preterm labor to evaluate if this hormone can be used as a predictive marker for preterm labor
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Singleton pregnancy.
-
Age between 17 - 35 years.
-
Gestational age between 28 and 36 weeks.
-
Diagnosis of threatened preterm labor is based on the American College of Obstetricians and Gynaecologists Guidelines (ACOG, 2003): Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation > 1 and < 4 cm, and/or Cervical effacement ≥ 80%.
Exclusion Criteria:
-
Preterm rupture of membranes.
-
Any uterine anomalies or cervical incompetence.
-
Chronic illness such as chronic hypertension or kidney disease.
-
Diabetes mellitus.
-
Abruptio placenta.
-
Preeclampsia and HELLP syndrome.
-
Fetal anomalies.
-
IUGR.
-
Smoking.
-
Clinical signs of intrauterine infection eg (uterine tenderness, foul vaginal discharge, maternal pyrexia ≥ 38°C and/or maternal leucocytosis).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Ainshams Maternity hospital | Cairo | Egypt | 133119 |
Sponsors and Collaborators
- Ain Shams Maternity Hospital
Investigators
- Principal Investigator: Mohamed S. Elsafty, M.D., Ain Shams University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- mai-01110333535
- MAI-01110333535m
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Pregnant Women With Threatened Preterm Labor |
---|---|
Arm/Group Description | pregnant healthy women aged from 17 to 35 who suffered from symptoms of threatened PTL in the form of Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation > 1 and < 4 cm, and/or Cervical effacement ≥ 80%. then, collection of blood sample and tocolysis adminstration will be done investigators obtained a blood sample from all patient to measure the serum level of ACTH. all patients with threatened preterm labor will received a fixed regimen of tocolysis in the form of nifedipine (Epilate) 10 mg orally every 15 minutes for the first hour or until cessation of uterine contractions. Then, 1-2 tablets 4 times daily of slowly releasing nifedipine (epilat retard 20 mg tablet). All women will be followed up till delivery. After delivery, investigators devide the pateints into 2 groups (full term delivery & preterm delivery) and investigators compare between these 2 groups by level of hormone. |
Period Title: Overall Study | |
STARTED | 262 |
COMPLETED | 262 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Preterm Group | Full Term Group | Total |
---|---|---|---|
Arm/Group Description | pregnant healthy female aged from 17 to 35 who suffered from symptoms of threatened preterm labor. investigators obtained a blood sample from all patient to measure the serum level of ACTH. all patients with threatened preterm labor received a fixed regimen of tocolysis in the form of nifedipine (Epilate) 10 mg orally every 15 minutes for the first hour or until cessation of uterine contractions. Then, 60 - 160 mg/day (1-2 tablets 3 times daily) of slowly releasing nifedipine (epilat retard 20 mg tablet). The patients will also receive 6 mg dexamethasone every 12 hours for 4 doses. All women followed up till delivery. this group delivered preterm (before 37 weeks of gestation) | pregnant healthy female aged from 17 to 35 who suffered from symptoms of threatened preterm labor. investigators obtained a blood sample from all patient to measure the serum level of ACTH. all patients with threatened preterm labor received a fixed regimen of tocolysis in the form of nifedipine (Epilate) 10 mg orally every 15 minutes for the first hour or until cessation of uterine contractions. Then, 60 - 160 mg/day (1-2 tablets 3 times daily) of slowly releasing nifedipine (epilat retard 20 mg tablet). The patients will also receive 6 mg dexamethasone every 12 hours for 4 doses. All women followed up till delivery. this group delivered full term (after 37 weeks of gestation) | Total of all reporting groups |
Overall Participants | 161 | 101 | 262 |
Age (years) [Median (Inter-Quartile Range) ] | |||
Median (Inter-Quartile Range) [years] |
26
|
26
|
26
|
Sex: Female, Male (Count of Participants) | |||
Female |
161
100%
|
101
100%
|
262
100%
|
Male |
0
0%
|
0
0%
|
0
0%
|
gestational age at admission (weeks) [Median (Inter-Quartile Range) ] | |||
Median (Inter-Quartile Range) [weeks] |
31
|
31
|
31
|
Outcome Measures
Title | Evaluate if ACTH Can be Used as a Predictive Marker for Preterm Labor |
---|---|
Description | measurement of maternal serum ACTH in women daignosed as threatened preterm labor to evaluate if this hormone can be used as a predictive marker for preterm labor |
Time Frame | 9 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Preterm Group | Full Term Group |
---|---|---|
Arm/Group Description | group of patients who delivered before 37 weeks of gestation | group of patients who delivered after 37 weeks of gestation |
Measure Participants | 161 | 101 |
Median (Inter-Quartile Range) [pg/ml] |
23.4
|
19.3
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Preterm Group, Full Term Group |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | <0.001 |
Comments | ||
Method | U statistic | |
Comments |
Adverse Events
Time Frame | ||
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Pregnant Women With Threatened Preterm Labor | |
Arm/Group Description | pregnant healthy women aged from 17 to 35 who suffered from symptoms of threatened PTL in the form of Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation > 1 and < 4 cm, and/or Cervical effacement ≥ 80%. then, collection of blood sample and tocolysis adminstration will be done investigators obtained a blood sample from all patient to measure the serum level of ACTH. all patients with threatened preterm labor will received a fixed regimen of tocolysis in the form of nifedipine (Epilate) 10 mg orally every 15 minutes for the first hour or until cessation of uterine contractions. Then, 1-2 tablets 4 times daily of slowly releasing nifedipine (epilat retard 20 mg tablet). All women will be followed up till delivery. After delivery, investigators devide the pateints into 2 groups (full term delivery & preterm delivery) and investigators compare between these 2 groups by level of hormone. | |
All Cause Mortality |
||
Pregnant Women With Threatened Preterm Labor | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Pregnant Women With Threatened Preterm Labor | ||
Affected / at Risk (%) | # Events | |
Total | 0/0 (NaN) | |
Other (Not Including Serious) Adverse Events |
||
Pregnant Women With Threatened Preterm Labor | ||
Affected / at Risk (%) | # Events | |
Total | 0/0 (NaN) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams |
---|---|
Organization | Ain Shams University Maternity Hospital |
Phone | 01003922211 ext 002 |
dr.mai_elshahm@yahoo.com |
- mai-01110333535
- MAI-01110333535m